Literature DB >> 19049709

Nephrogenic systemic fibrosis: the first Italian gadolinium-proven case.

S Bainotti1, E Rota, M Bertrero, O Tamburrini, A Balducci, M Formica.   

Abstract

Nephrogenic systemic fibrosis (NSF) is a systemic disease, recently described in patients with advanced chronic kidney disease (CKD), characterized by progressive scleromyxedema-like fibrotic involvement mainly of the skin. We describe the case of a 66-year-old woman on chronic hemodialysis for end-stage renal failure, also affected by hypothyroidism, secondary hyperparathyroidism and occluding arteriopathy, for which she underwent a contrast-enhanced magnetic resonance angiography of the lower limbs in February 2007. One month later, she began complaining of progressive, painful distal lower limb stiffness, which subsequently spread to all four limbs and to the whole trunk. A deep-skin biopsy, taken from an affected area, showed gadolinium deposits. The case reported is, to best of our knowledge, the first Italian case of NSF. This diagnosis should be considered with care in CKD patients with a recent exposure to a gadolinium-based contrast agent, complaining of limb stiffness, especially in the presence of risk factors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19049709     DOI: 10.5414/cnp70514

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  3 in total

1.  Nephrogenic systemic fibrosis: an unusual scleroderma-like fibrosing disorder.

Authors:  Eugenia Rota; Maria Gabriella Nallino; Serena Bainotti; Marco Formica
Journal:  Rheumatol Int       Date:  2009-08-20       Impact factor: 2.631

2.  Nephrogenic systemic fibrosis: review of 408 biopsy-confirmed cases.

Authors:  Zhitong Zou; Lin Ma
Journal:  Indian J Dermatol       Date:  2011-01       Impact factor: 1.494

3.  Urinary mitochondrial DNA level as a biomarker of tissue injury in non-diabetic chronic kidney diseases.

Authors:  Zhongping Wei; Bonnie Ching-Ha Kwan; Kai Ming Chow; Phyllis Mei-Shan Cheng; Cathy Choi-Wan Luk; Ka-Bik Lai; Philip Kam-Tao Li; Cheuk Chun Szeto
Journal:  BMC Nephrol       Date:  2018-12-19       Impact factor: 2.388

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.